Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
USPTO ignites CRISPR/Cas9 patent battle
Americas
Scientists from two US universities will fight out the ownership of the intellectual property rights to the CRISPR/Cas9 technology after the US Patent and Trademark Office agreed to initiate an interference proceeding.   13 January 2016
US politicians demand NIH steps in and halts price ‘gouging’
Americas
US politicians have called on the National Institute of Health to reveal when it would use its right to make companies license certain patents in order to stop drugs being priced too high.   12 January 2016
Americas
Law firm Orrick, Herrington & Sutcliffe has added Richard DeLucia, Elizabeth Gardner, Antony Pfeffer and Patrick Herman to the firm’s patent litigation group in New York.   12 January 2016
Americas
Biopharmaceutical company Shire has completed the $32 billion takeover of US-based Baxalta   11 January 2016
Europe
US-based gene sequencing company Illumina has claimed that The Doctors Laboratory’s use of the Harmony prenatal test provided by Ariosa Diagnostics infringes its patent.   8 January 2016
Americas
Enzo Biochem has agreed a $9 million settlement with Agilent Technologies in a patent infringement lawsuit centring on technology used in detecting nucleic acid.   7 January 2016
Americas
A US district court has ordered a stay in a patent infringement case between Jawbone and Fitbit as the International Trade Commission is due to issue its ruling on another case centring on the same patents.   6 January 2016
Americas
Biopharmaceutical company Celgene and India-based rival Natco Pharma have settled a lawsuit centring on the alleged infringement of a number patents covering the Revlimid drug.   5 January 2016
Americas
Biopharmaceutical company Suven Life Sciences has been granted three product patents for the non-chemical entities for the treatment of neurodegenerative diseases including Alzheimer’s.   5 January 2016
Big Pharma
UK law firm Potter Clarkson has elected Michael Pears as partner in the firm’s biotechnology and pharmaceuticals department.   5 January 2016